Jubilant plans new niacinamide facility

- Last updated on GMT

Related tags: Manufacturing

Jubilant Organosys will build a new niacinamide and 3-Cyanopyridine plant to cater for growing demand in the drug and nutrition industries.

The facility, which is expected to be operational at the end of next year, will produce 10,000 tonnes of each compound per year primarily for the vitamin B3 manufacturing industry as Jubilant CEO Pramod Yadav explained.

Our decision to set up a new facility for niacinamide reflects our commitment to our customers and vitamin B3 market. Through our in-house research we have developed a very cost efficient and environmental friendly process for the manufacture of these products which will translate into value for our customers​.”

For the pharmaceutical industry, the custom research and manufacturing service (CRAMS) firm’s new facility will increase the global supply of key components for a wide range of products, including diabetes treatments and blood pressure drugs.

Related news

Show more

Related products

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Related suppliers

Follow us

Products

View more

Webinars